In a report released today, Matt Larew from William Blair maintained a Hold rating on Amedisys (AMED – Research Report). The company’s shares ...

Amedisys (Nasdaq: AMED) exceeded Wall Street expectations in its first-quarter results for 2025. The company’s home health segment benefited from ...

BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported first-quarter earnings of $61 million. On a per-share basis, the Baton Rouge, Louisiana-based company ...

Amedisys (AMED) is expected to deliver a year ... earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the ...

U.S. crude oil inventories rose for a fourth consecutive week amid higher net imports, while refineries ramped up their capacity use. Commercial crude oil stocks excluding the Strategic Petroleum ...

It has been about a month since the last earnings report for Amedisys (AMED). Shares have added about 1.3% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...

Amedisys shares have climbed 3% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $93.56, an increase of almost 3% in the last 12 months.

BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported first-quarter earnings of $61 million. On a per-share basis, the Baton Rouge, Louisiana-based company said it ...